Danielle Heath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danielle Heath has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amie Wong
Rady Children's Hospital, San Diego, CA, USA
1 shared publicationAmy Kimball
Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, CA, USA
1 shared publicationElaine Sim
Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, GA, USA
1 shared publicationGale Romanowski
Rady Children's Hospital, San Diego, CA, USA
1 shared publication- Halli Helgeson
Department of Pharmacy, Children's Minnesota, Minneapolis, MN, USA
1 shared publication Jane Kang
Rady Children's Hospital, San Diego, CA, USA
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Springer Nature in Journal of Perinatology
Tiny doses, big impact: Optimizing sedation weaning to reduce opioid use in a Level IV NICU
Objective: Infants in the NICU often require prolonged sedation, increasing risk for iatrogenic withdrawal. We aimed to reduce mean opioid exposure by 20% (26 to 21 days) by May 2023, with sustained improvement through May 2024. Study design: A multidisciplinary team used the Model for Improvement with iterative Plan-Do-Study-Act cycles and EHR tools to implement a standardized sedation-weaning guideline. Applicable outcome, process, and balancing measures were analyzed using statistical process control charts. Results: Among patients receiving >4 days of opioids, mean exposure decreased from 26 to 17 days, length of stay from 70 to 50 days; and overall dexmedetomidine exposure from 18 to 12 days. Adherence to individualized weaning plans improved and feedback indicated effective withdrawal management. Conclusions: Standardized weaning reduced opioid exposure, LOS, and sedative use, enhancing safety, care quality, and NICU capacity.
- 29 April 2026
- Published by Springer Nature in Journal of Perinatology
Open AccessTiny doses, big impact: Optimizing sedation weaning to reduce opioid use in a Level IV NICU
Objective: Infants in the NICU often require prolonged sedation, increasing risk for iatrogenic withdrawal. We aimed to reduce mean opioid exposure by 20% (26 to 21 days) by May 2023, with sustained improvement through May 2024. Study design: A multidisciplinary team used the Model for Improvement with iterative Plan-Do-Study-Act cycles and EHR tools to implement a standardized sedation-weaning guideline. Applicable outcome, process, and balancing measures were analyzed using statistical process control charts. Results: Among patients receiving >4 days of opioids, mean exposure decreased from 26 to 17 days, length of stay from 70 to 50 days; and overall dexmedetomidine exposure from 18 to 12 days. Adherence to individualized weaning plans improved and feedback indicated effective withdrawal management. Conclusions: Standardized weaning reduced opioid exposure, LOS, and sedative use, enhancing safety, care quality, and NICU capacity.